News

Tulane University and 60 Degrees Pharmaceuticals Partner to Study New Lyme Disease Treatment

60 Degrees Pharmaceuticals, a company focused on developing medicines for infectious diseases, has entered a research partnership with Tulane University… Read More

2 weeks ago

10x Genomics and A*STAR Singapore Team Up to Revolutionize Cancer and Inflammatory Disease Research

10x Genomics, a leader in spatial biology and single-cell analysis, has joined forces with the Genome Institute of Singapore (A*STAR… Read More

2 weeks ago

Lisata and WARPNINE Complete First Stage of Promising Pancreatic Cancer Trial in Australia

Lisata Therapeutics and WARPNINE, a non-profit clinical research group in Western Australia, have announced the successful completion of patient enrollment… Read More

2 weeks ago

New Study Finds Key Marker That May Improve Pancreatic Cancer Treatment for Younger Patients

Sapu Biosciences, a subsidiary of GMP Biotechnology Limited, has partnered with Oncotelic Therapeutics to publish groundbreaking research that could change… Read More

2 weeks ago

ASAP and Allen Institute Join Forces to Unlock Insights Into Parkinson’s and Neurodegenerative Diseases

The Allen Institute and the Aligning Science Across Parkinson’s (ASAP) initiative have teamed up in a groundbreaking effort to advance… Read More

2 weeks ago

Amphix Bio Achieves Major Milestone with Orphan Drug Designation for AMFX-200 in Spinal Cord Injury Treatment

Amphix Bio, an emerging leader in regenerative medicine, has announced a significant breakthrough: the U.S. FDA has granted orphan drug… Read More

2 weeks ago

Innovent Biologics’ IBI343 Shines in Nature Medicine: A Major Step Forward in Gastric Cancer Treatment

Innovent Biologics, Inc., a leading biopharmaceutical company focused on developing and commercializing innovative therapies, has announced a significant milestone. The… Read More

2 weeks ago

Sarepta’s Bold New Chapter: Reshaping Strategy and Elevating ELEVIDYS for the Future

Sarepta Therapeutics, a pioneer in precision genetic medicines for rare diseases, is setting the stage for a transformative future. Riding… Read More

2 weeks ago

Acadia Pharmaceuticals Projects $14 Billion Annual Revenue with New R&D Leadership and Expanding Drug Pipeline

San Diego, CA, July 18, 2025  Acadia Pharmaceuticals, a leader in treatments for neurological and rare diseases, has unveiled an… Read More

2 weeks ago

Zimmer Biomet to Acquire Monogram Technologies in $177 Million Deal

Warsaw, IN, July 18, 2025 – Zimmer Biomet Holdings, Inc., a leading innovator in medical technology, has announced a definitive… Read More

2 weeks ago